News

See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.

University of Wisconsin–Madison scientists are poised to gain a better understanding of how to treat a progressive scarring disease of the lungs that kills an estimated 40,000 people every year in the United States.

Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.

School of Pharmacy researchers in fiscal year 2021–22 received four patents for innovations in drug discovery and delivery.

Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move therapies from the lab into the clinic.

School of Pharmacy Assistant Professor Quanyin Hu and his CIPT Lab team, along with research collaborators, develop a gel that effectively keeps in check certain tumors, with their findings published in Nature Communications By Eric Hamilton …

Professor Seungpyo Hong and alumna Heidi Mansour are selected for their contributions to nanotechnology and pulmonary disease treatment.

With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.

With funding from the Discovery to Product program, Professor Seungpyo Hong and his collaborators are accelerating their research on idiopathic pulmonary fibrosis.

Professor Seungpyo Hong is the Chair’s first recipient, adding to a growing roster of alumni-supported professorships By Katie Ginder-Vogel The oldest son of dairy farmers, Milton Henrichs (BS ‘44) grew up north of Green Bay, …

By Eric Hamilton This article originally appeared on UW–Madison’s news page. University of Wisconsin–Madison researchers have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as …

Professors Seungpyo Hong, Sandro Mecozzi, Lingjun Li and Glen Kwon are combining their expertise to create a new research center that will improve the efficacy of new drug leads.

A new three-year grant from the National Science Foundation will support Professor Seungpyo Hong’s research into improving the efficacy of chemotherapies.

New research by Professor Seungpyo Hong and his collaborators demonstrates improved methods for capturing circulating tumor cells on clinical samples for the first time.

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.

Capio Biosciences, Inc., a cancer diagnostic biotech startup, is partnering with the University of Wisconsin–Madison on research that will further develop novel technology in cancer detection. The Research Service Agreement (RSA) will support the research of …

Seungpyo Hong, professor in the Pharmaceutical Sciences Division, is among four researchers from the University of Illinois Chicago on a newly funded R01 grant from the NIH/NIAMS for the project “Non-covalent Nrf2 Activators for the …

Seungpyo Hong, professor in the Pharmaceutical Sciences Division, who recently joined the UW-Madison faculty is eager to talk about his research in the area of biomimetics and nanotechnology. An engineer by training with degrees in …